Antibiotic price drop could stop millions from developing tuberculosis: New agreement secures 66% reduction in cost of rifapentine, which prevents ‘latent’ TB from becoming active. Available to those who could afford it, it has, until now, been “completely unaffordable” in developing countries. submitted by /u/mvea
[link] [comments]


from Health https://ift.tt/327Miz0
Share To:

Unknown

Post A Comment:

0 comments so far,add yours